Post-transplant diabetes mellitus in pediatric liver transplantation

Eba Hathout1, Estella Alonso, Ravinder Anand

  • 1Division of Pediatric Endocrinology and Diabetes, Loma Linda University, Loma Linda, CA 92354, USA. ehathout@llu.edu

Insights

Pediatric liver transplant recipients over age 5, hospitalized at transplant, or on early steroids/tacrolimus face higher risks of gastrointestinal issues and post-transplant diabetes mellitus (PTDM). Monitoring is crucial for early detection and management.

Area of Science:

  • Pediatric Gastroenterology
  • Transplant Hepatology
  • Immunology

Background:

  • Gastrointestinal (GI) complications and post-transplant diabetes mellitus (PTDM) are significant concerns in pediatric liver transplantation.
  • Identifying risk factors is essential for proactive management and improving outcomes in this vulnerable population.

Purpose of the Study:

  • To identify recipient and donor characteristics associated with the development of GI and/or PTDM in children undergoing their first liver transplant.
  • To analyze factors contributing to early-onset GI/PTDM within 30 days post-transplantation.

Main Methods:

  • Analysis of data from 1611 pediatric patients undergoing their first liver transplant, sourced from the SPLIT database.
  • Evaluation of recipient factors (age, hospitalization, diagnosis, immunosuppression) and donor factors (type, age, CMV status).
  • Multivariate analyses to determine statistically significant associations with GI/PTDM development.

Main Results:

  • Gastrointestinal issues and/or PTDM occurred in 13% (214/1611) of pediatric liver transplant recipients.
  • Early GI/PTDM (within 30 days) was diagnosed in 78% (166/214) of affected individuals.
  • Factors associated with increased early GI/PTDM incidence included: age >5 years at transplant, hospitalization at transplant, primary diagnosis other than biliary atresia, early steroid use, and tacrolimus use.

Conclusions:

  • Age, hospitalization status, specific primary diagnoses, and early immunosuppressive strategies (steroids, tacrolimus) are key predictors of early GI/PTDM after pediatric liver transplant.
  • Routine monitoring for GI complications and PTDM is recommended for comprehensive short- and long-term care of pediatric liver transplant recipients.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...